1. Home
  2. WOLF vs REPL Comparison

WOLF vs REPL Comparison

Compare WOLF & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wolfspeed Inc.

WOLF

Wolfspeed Inc.

HOLD

Current Price

$25.69

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$11.81

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WOLF
REPL
Founded
1987
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
WOLF
REPL
Price
$25.69
$11.81
Analyst Decision
Hold
Buy
Analyst Count
2
8
Target Price
★ $27.50
$19.50
AVG Volume (30 Days)
★ 3.4M
1.9M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $1,385,982,000.00
N/A
Revenue This Year
$14.87
N/A
Revenue Next Year
$4.07
$497.81
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 19.00
N/A
52 Week Low
$13.49
$1.50
52 Week High
$80.82
$16.33

Technical Indicators

Market Signals
Indicator
WOLF
REPL
Relative Strength Index (RSI) 43.10 37.97
Support Level $23.31 $6.81
Resistance Level $29.70 $12.50
Average True Range (ATR) 2.65 0.70
MACD -0.55 -0.14
Stochastic Oscillator 21.60 22.68

Price Performance

Historical Comparison
WOLF
REPL

About WOLF Wolfspeed Inc.

Wolfspeed Inc is an innovator of wide bandgap semiconductors, focused on silicon carbide materials and devices for power applications. Its product families include silicon carbide materials and power devices. Its products are targeted for various applications in the Automotive domain, including electric vehicles and fast charging, as well as existing and emerging applications in the Industrial & Energy domain such as AI data centers, grid modernization and renewable energy and storage as well as aerospace and defense. The company also use contract manufacturers, some of which include captive lines, for certain products and aspects of product fabrication, assembly and packaging. The company has one reportable segment. Majority of revenue comes from United States followed by Hong Kong.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

Share on Social Networks: